$3.280
-0.197 (-6.02%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Aclaris Therapeutics, Inc. (ACRS) Moving Averages Convergence Divergence (MACD) indicator is -0.59, suggesting ACRS is Strong sell.
Aclaris Therapeutics, Inc. (ACRS) 20-Day simple moving average is 4.40, while Aclaris Therapeutics, Inc. (ACRS) share price is $—, making it Sell.
Aclaris Therapeutics, Inc. (ACRS) 60-Day simple moving average is 5.36, while Aclaris Therapeutics, Inc. (ACRS) share price is $—, making it Sell.
Technical Analysis for ACRS
AI Technical ACRSAs of 2026-10-10, the technical board for Aclaris Therapeutics, Inc. (ACRS) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $3.28 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 27.969, MACD stands at -0.594 (Sell), Stochastic %K stands at 8.747 (Buy), Stochastic %D stands at 10.819 and CCI stands at -90.063.
ACRS trades below the 60-day SMA (5.36) and below the 200-day SMA (4.48). Immediate resistance sits at Classic R1 4.29, then R2 4.97. Support sits at Classic S1 3.07, then S2 2.51.
Aclaris Therapeutics, Inc. (ACRS) Support & Resistance Level
Aclaris Therapeutics, Inc. (ACRS) Technical Indicators
2026-10-10
| Name | Value |
|---|---|
| RSI_14 | 27.969 |
| STOCHk_14_3_3 | 8.747 |
| STOCHd_14_3_3 | 10.819 |
| CCI_20 | -90.063 |
| AO_5_34 | -1.467 |
| MOM_10 | -1.110 |
| MACD_12_26_9 | -0.594 |
Aclaris Therapeutics, Inc. (ACRS) Relative Strength Index (RSI_14) is 27.969, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) Stochastic %K is 8.747, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) Stochastic %D is 10.819, creating a Buy signal.
Aclaris Therapeutics, Inc. (ACRS) CCI_20 is -90.063, creating a Neutral signal.
Aclaris Therapeutics, Inc. (ACRS) Awesome Oscillator (AO) is -1.467, creating a Sell signal.
Aclaris Therapeutics, Inc. (ACRS) Momentum (MOM) is -1.110, creating a Sell signal.
Aclaris Therapeutics, Inc. (ACRS) Moving Average Convergence Divergence (MACD) is -0.594, creating a Sell signal.
Aclaris Therapeutics, Inc. (ACRS) Moving Average
2026-10-10
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 3.444 | Sell |
| MA_10 | 3.621 | Sell |
| MA_20 | 4.403 | Sell |
| MA_60 | 5.360 | Sell |
| MA_200 | 4.478 | Sell |
| MA_250 | 4.119 | Sell |
Aclaris Therapeutics, Inc. (ACRS) 5-Day simple moving average is 3.444, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 10-Day simple moving average is 3.621, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 20-Day simple moving average is 4.403, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 60-Day simple moving average is 5.360, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 200-Day simple moving average is 4.478, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
Aclaris Therapeutics, Inc. (ACRS) 250-Day simple moving average is 4.119, while Aclaris Therapeutics, Inc. (ACRS) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.